Last reviewed · How we verify
NCT05138107
Prospective Placebo-controlled Study of Synochi Scar Spray
NA trial testing Synochi Scar Spray Cosmetic in Burns Multiple in 28 participants. Status unknown.
17 May 2024
Quick facts
| Lead sponsor | Synochi, LLC |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 28 |
| Start date | 1 July 2022 |
| Primary completion | 17 May 2024 |
| Estimated completion | 17 July 2025 |
Drugs / interventions tested
- Synochi Scar Spray Cosmetic
- Synochi Scar Spray Placebo
Conditions studied
- Burns Multiple — all drugs for Burns Multiple →
Sponsor
Synochi, LLC
Who can join
Adults 22 to 50, any sex, with Burns Multiple. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized, double-blind, placebo controlled, prospective, split-scar study of severe burn victims with autologous skin transplants. 9 months intervention time and 3 months follow-up, photographic scar documentation, self-and observer questionnaires throughout
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05138107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burns Multiple
Currently open trials in the same condition.
- NCT06737991 — Effects of Chest Expansion Exercises on Thoracic Expansion and VO2 Max in Children With Chest Burn · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05138107 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Synochi, LLC
- Last refreshed: 16 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing